DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Braun J, Baraliakos X, Deodhar A. et al.
Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study.
Rheumatology (Oxford) 2018;
DOI: 10.1093/rheumatology/key375..
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.